Gradient Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5	Closed	-$1K	–	1301
2021 Q1	$1K	Hold	5	–	–	﹤0.01%	1133
2020 Q4	$1K	Hold	5	–	–	﹤0.01%	1112
2020 Q3	$1K	Sell	5 -19	-79%	-$2.05K	﹤0.01%	1116
2020 Q2	$3K	Sell	24 -183	-88%	-$19.4K	﹤0.01%	858
2020 Q1	$19K	Sell	207 -10,621	-98%	-$1.04M	﹤0.01%	541
2019 Q4	$1.17M	Buy	10,828 +1,769	+20%	+$189K	0.05%	191
2019 Q3	$887K	Buy	9,059 +1,493	+20%	+$168K	0.04%	201
2019 Q2	$991K	Buy	7,566 +3,064	+68%	+$395K	0.05%	189
2019 Q1	$609K	Sell	4,502 -1,674	-27%	-$208K	0.04%	170
2018 Q4	$601K	Sell	6,176 -2,080	-25%	-$246K	0.04%	173
2018 Q3	$1.15M	Buy	8,256 +2,242	+37%	+$281K	0.06%	147
2018 Q2	$747K	Buy	6,014 +1,754	+41%	+$205K	0.04%	171
2018 Q1	$475K	Buy	4,260 +895	+27%	+$107K	0.03%	189
2017 Q4	$402K	Buy	3,365 +791	+31%	+$96.3K	0.02%	207
2017 Q3	$361K	Buy	2,574 +19	+0.7%	+$2.58K	0.02%	195
2017 Q2	$311K	Buy	2,555 +189	+8%	+$22K	0.02%	194
2017 Q1	$287K	Sell	2,366 -197	-8%	-$25.4K	0.02%	175
2016 Q4	$314K	Buy	2,563 +445	+21%	+$54.5K	0.03%	153
2016 Q3	$260K	Buy	2,118 +106	+5%	+$13.6K	0.03%	172
2016 Q2	$235K	Sell	2,012 -136	-6%	-$19.3K	0.03%	172
2016 Q1	$299K	Buy	+2,148	New	+$315K	0.04%	147